Name (Synonyms) | Correlation | |
---|---|---|
drug1848 | Placebo of excipient(s) will be administered Wiki | 0.71 |
drug1323 | Lactoferrin (Apolactoferrin) Wiki | 0.71 |
drug1000 | Glucose tablets Wiki | 0.71 |
drug264 | Azithromycin 250 MG Wiki | 0.71 |
drug267 | Azithromycin 500Mg Oral Tablet Wiki | 0.71 |
Name (Synonyms) | Correlation | |
---|---|---|
D013577 | Syndrome NIH | 0.08 |
D055371 | Acute Lung Injury NIH | 0.07 |
D012127 | Respiratory Distress Syndrome, Newborn NIH | 0.07 |
D012128 | Respiratory Distress Syndrome, Adult NIH | 0.06 |
D003141 | Communicable Diseases NIH | 0.06 |
D011014 | Pneumonia NIH | 0.04 |
D007239 | Infection NIH | 0.04 |
D045169 | Severe Acute Respiratory Syndrome NIH | 0.04 |
D018352 | Coronavirus Infections NIH | 0.03 |
There are 2 clinical trials
To find the effectiveness of hydroxychloroquine alone and adjuvant with azithromycin in mild to severe Covide-19 pneumonia patients admitted to Coronavirus cell/ward of Ayub Teaching hospital, Abbottabad Pakistan. A single centered, single-blind randomized control trial study.
Description: National Early Warning Score equal to zero is when patients recovered clinically. Respiration 14-20breaths/minute, oxygen saturation percent greater than 96, (without breathing aid), systolic blood pressure 111-180 mmhg, pulse 60-90 beats.minute, alert consciousness and 35.1-38 degree Celsius body temperature.
Measure: National Early Warning Score equal to zero Time: 3-5 DaysDescription: below 3.0 miligram/Liter of blood sample
Measure: C-reactive proteins Time: 3-5 DaysDescription: 1000 -4800 lymphocytes in 1 microliter of blood
Measure: Lymphocyte Count Time: 3-5daysDescription: less than 250 ng/mL, or less than 0.4 mcg/mL of blood sample
Measure: d-dimers Time: 3-5daysThis study investigates the efficay and tolerance of 5-days course of hydroxychloroquine or hydroxychloroquine and azithromycin of patients with COVID-19 infection. The investigators will undertake a randomized, double-blind, controlled Trial in the region of Sousse Tunisia
Description: Clinical recovery is defined as a complete resolution clinical signs appeared during the medical history and related to COVID-19.
Measure: Clinical recovery at day-14, from the start of treatment. Time: 14 daysDescription: RT-PCR will be realized in same laboratory
Measure: Viral Clearance via RT-PCR at day 5- 7-10 and day 14 Time: 5- 7-10 and day 14